Surgery Godfather-Chapter 1980 - 1345: The Return of Director Zhu

A black Maybach sedan smoothly drove into the Nandu High-tech Zone. The windows were tinted with deep anti-peep film, reflecting the modern buildings and green belts swiftly passing by on both sides of the road. Inside the car, Zhu Cheng set down the latest copy of the "Global Medical Cost-Effectiveness Analysis Report on System Regulation Therapy and K Therapy," took off his gold-rimmed glasses, and rubbed his brow.

At over forty years old, time had not left many marks on his face, but instead, it had cultivated an elegant and capable demeanor. His well-tailored dark gray custom suit, meticulous hairstyle, and the understated Patek Philippe on his wrist all attested to his current status and position—as the President of the international headquarters of the top health insurance company under Anning Group, with an annual salary over a hundred million, managing a health insurance fund pool worth hundreds of billions of dollars.

The car stopped at the entrance of Ruixing Medical Building. The assistant quickly got out to open the car door for him. Zhu Cheng nodded slightly, stepped out, and looked up at the towering glass-walled building ahead, his eyes complex.

"President Zhu, Mr. Huang Jiacai from Ruixing Medical is already waiting in the meeting room," the assistant whispered.

"Good." Zhu Cheng withdrew his gaze, resumed the composure of a business elite, and walked into the building under the guidance of Ruixing staff. His return to the country was not just for family visits; the most important business was to negotiate with Ruixing Medical and the Sanbo Research Institute behind it to include the System Regulation Therapy and its flagship application, the K Therapy, into the reimbursement directory of the "Global Health Protection" high-end medical insurance. This was not only a business cooperation but an important strategic layout based on his professional judgment for the company’s future.

The meeting was held in the top-floor meeting room of Ruixing. Huang Jiacai personally received him, and both teams conducted in-depth and efficient discussions on the core concepts, efficacy data, cost structure, risk control, and potential new therapies derived in the future from System Regulation Therapy. Zhu Cheng’s profound understanding of medical expertise, and his keen grasp of insurance actuarial and risk control, left a strong impression on Huang Jiacai.

"President Zhu is indeed an expert who gets straight to the point," Huang Jiacai praised, "Incorporating such highly individualized, dynamically processed therapies like system regulation into the standard insurance framework indeed faces many challenges. But as you said, its potential to fundamentally adjust the system, reducing long-term complications and recurrence risks, may be more cost-effective in the long run and aligns more with the trending evolution of the insurance philosophy ’prevention over cure.’

Zhu Cheng smiled, "President Huang overpraises, I’m just thinking from both the user’s and payer’s dual perspectives. System regulation will undoubtedly be the new model of future medicine, and Anning ’Global Health Protection’ is willing to be the first to take the plunge."

Preliminary cooperation intentions were smoothly reached. Both parties agreed that their respective teams would further refine the plan, especially the assessment standards and fee settlement mechanisms for different diseases and different stages. 𝗳𝗿𝐞𝕖𝘄𝗲𝕓𝗻𝚘𝚟𝕖𝐥.𝚌𝕠𝕞

After the meeting, Huang Jiacai personally escorted Zhu Cheng to the elevator. Before parting, Zhu Cheng suddenly asked, "President Huang, may I ask if Professor Yang Ping is at the institute today? If convenient, I would like to visit in a personal capacity."

Huang Jiacai pondered briefly, communicated with Sanbo, and then smiled, "Professor Yang just finished a case discussion and is now available. He heard about your return and is very eager to see you."

"Thank you." Zhu Cheng nodded.

Half an hour later, Zhu Cheng’s car drove into the relatively understated and serene Sanbo Research Institute. Compared to the modern business atmosphere of Ruixing Building, this place, with greenery all around, had a more tranquil academic focus.

Led by Tang Shun, Zhu Cheng entered Yang Ping’s office. The room was spacious and bright, simply furnished, with the most striking feature being a bookshelf occupying almost an entire wall, filled with professional books and literature, alongside several lush green plants in the corner.

"Professor Yang, long time no see." Zhu Cheng offered his hand proactively, with sincere tone.

Yang Ping shook his hand, calmly observing this former peer and now insurance giant executive. "Mr. Zhu, please have a seat. President Huang mentioned that you have insights on incorporating system regulation therapy into insurance."

"I dare not call them insights in your presence, just some thoughts from another angle." Zhu Cheng sat on the sofa, relaxed yet respectful, "I’ve reviewed many K Therapy, especially cases like Sisi’s cured late-stage tumor patient data—truly astonishing. It’s not just curing a disease but changing the destiny trajectory of a person, a family. From an insurance perspective, this is priceless. But how to transform this ’priceless’ aspect into a sustainable payment model is a challenge."

The two did not engage in much small talk, diving directly into the subject. Zhu Cheng displayed some of the analysis models he brought, discussing the possibility of setting payment nodes according to different disease stages and regulation targets. Yang Ping explained, from the perspective of medical practice, the complexity and dynamic nature of the system regulation, emphasizing the difficulty of balancing standardized assessment and individualized flexible adjustment.

"We might need a ’framework contract plus dynamic regulation’ model," Zhu Cheng thought aloud, "to set core payment standards, but also leave a certain ’expert judgment floating space,’ with a special committee to decide the payment reasonableness for special cases. Of course, this requires a high level of trust and transparency."

Yang Ping nodded, "Trust is the foundation, data transparency is the key. All our treatment processes and data are traceable on the platform, perhaps this can be the foundation to establish such trust and transparency."